Subtopic Deep Dive

← Psidium guajava Extracts and Applications

Antimicrobial Properties of Psidium guajava
Research Guide

What is Antimicrobial Properties of Psidium guajava?

Antimicrobial properties of Psidium guajava refer to the antibacterial, antifungal, and anti-multidrug resistant activities exhibited by extracts from its leaves and fruits, primarily through mechanisms like membrane disruption and minimum inhibitory concentration determination.

Studies demonstrate Psidium guajava leaf extracts inhibit Gram-positive bacteria such as Staphylococcus aureus and Gram-negative like Escherichia coli (Biswas et al., 2013, 283 citations). Green synthesis using guava extracts produces TiO2 nanoparticles with enhanced antibacterial effects (Santhoshkumar et al., 2014, 503 citations). Over 10 key papers from 1997-2021 document these properties, with Rabe and Van Staden (1997, 564 citations) establishing early ethnopharmacological evidence.

Curated Papers

Key Challenges

Why It Matters

Guava extracts offer natural alternatives to combat antibiotic resistance, as shown in synergism studies with drugs against Staphylococcus aureus (Betoni et al., 2006, 357 citations). Applications include edible coatings with antimicrobial nanoparticles for fruit preservation (Jarma Arroyo et al., 2019, 240 citations). Wound healing extracts reduce infection risks in clinical settings (Chah et al., 2005, 291 citations), supporting low-cost, plant-based antimicrobials in resource-limited areas.

Key Research Challenges

Standardizing Extract Preparation

Variations in solvent extraction methods lead to inconsistent antimicrobial efficacy across studies. Biswas et al. (2013) used methanolic extracts against E. coli, while Arima and Danno (2002) isolated specific glycosides. Standardization of extraction protocols remains unresolved for reproducible MIC values.

Elucidating Mechanisms of Action

Precise pathways like membrane disruption require advanced assays beyond basic inhibition tests. Santhoshkumar et al. (2014) linked TiO2 nanoparticles to bacterial cell damage but lacked molecular details. Few studies identify target proteins or genetic responses in pathogens.

Clinical Translation Barriers

In vitro success against MDR pathogens does not guarantee in vivo efficacy due to bioavailability issues. Chassagne et al. (2021) reviewed plant antibacterials noting scalability gaps. Regulatory hurdles limit guava extracts from lab to therapeutic use.

Essential Papers

Antibacterial activity of South African plants used for medicinal purposes

T. Rabe, J. Van Staden · 1997 · Journal of Ethnopharmacology · 564 citations

Green synthesis of titanium dioxide nanoparticles using Psidium guajava extract and its antibacterial and antioxidant properties

Thirunavukkarasu Santhoshkumar, Abdul Abdul Rahuman, Chidambaram Jayaseelan et al. · 2014 · Asian Pacific Journal of Tropical Medicine · 503 citations

Green synthesized TiO2 NPs provides a promising approach can satisfy the requirement of large-scale industrial production bearing the advantage of low-cost, eco-friendly and reproducible.

Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases

Joyce Elaine Cristina Betoni, Rebeca Passarelli Mantovani, Lidiane Nunes Barbosa et al. · 2006 · Memórias do Instituto Oswaldo Cruz · 357 citations

Searches for substances with antimicrobial activity are frequent, and medicinal plants have been considered interesting by some researchers since they are frequently used in popular medicine as rem...

Phytochemical Analysis of Medicinal Plants Occurring in Local Area of Mardan

Abdul Wadood · 2013 · Biochemistry & Analytical Biochemistry · 348 citations

Medicinal plants have bioactive compounds which are used for curing of various human diseases and also play an important role in healing.Phytochemicals have two categories i.e., primary and seconda...

The phytochemistry and medicinal value of Psidium guajava (guava)

Sumra Naseer, Shabbir Hussain, Naureen Naeem et al. · 2018 · Clinical Phytoscience · 325 citations

Antibacterial and wound healing properties of methanolic extracts of some Nigerian medicinal plants

Kennedy F. Chah, C. A. Eze, C.E. Emuelosi et al. · 2005 · Journal of Ethnopharmacology · 291 citations

Antimicrobial Activities of Leaf Extracts of Guava (<i>Psidium guajava</i>L.) on Two Gram-Negative and Gram-Positive Bacteria

Bipul K. Biswas, Kimberly G. Rogers, Fredrick McLaughlin et al. · 2013 · International Journal of Microbiology · 283 citations

Aim. To determine the antimicrobial potential of guava ( Psidium guajava ) leaf extracts against two gram-negative bacteria ( Escherichia coli and Salmonella enteritidis ) and two gram-positive bac...

Reading Guide

Foundational Papers

Start with Rabe and Van Staden (1997, 564 citations) for ethnopharmacological baseline; Santhoshkumar et al. (2014, 503 citations) for nanoparticle applications; Betoni et al. (2006, 357 citations) for drug synergism evidence.

Recent Advances

Naseer et al. (2018, 325 citations) on phytochemistry; Jarma Arroyo et al. (2019, 240 citations) on edible coatings; Chassagne et al. (2021, 265 citations) for systematic antibacterial review.

Core Methods

MIC via broth dilution (Biswas et al., 2013); flavonoid isolation by chromatography (Arima and Danno, 2002); green NP synthesis with guava extract reduction (Santhoshkumar et al., 2014).

How PapersFlow Helps You Research Antimicrobial Properties of Psidium guajava

Discover & Search

Research Agent uses searchPapers with query 'Psidium guajava antimicrobial MIC' to retrieve top papers like Biswas et al. (2013); citationGraph reveals Rabe and Van Staden (1997, 564 citations) as hubs; findSimilarPapers expands to synergism studies (Betoni et al., 2006); exaSearch uncovers green synthesis variants (Santhoshkumar et al., 2014).

Analyze & Verify

Analysis Agent employs readPaperContent on Biswas et al. (2013) to extract MIC data for E. coli and S. aureus; verifyResponse with CoVe cross-checks claims against Chah et al. (2005); runPythonAnalysis plots dose-response curves from extracted tables using pandas and matplotlib; GRADE grading scores evidence quality for leaf extract efficacy.

Synthesize & Write

Synthesis Agent detects gaps in clinical trials via contradiction flagging across Betoni et al. (2006) and Chassagne et al. (2021); Writing Agent uses latexEditText for methods sections, latexSyncCitations to integrate 10+ references, latexCompile for full reports, and exportMermaid for MIC comparison diagrams.

Use Cases

"Compare MIC values of guava leaf extracts against S. aureus from 5 papers"

Research Agent → searchPapers → readPaperContent (Biswas 2013, Betoni 2006) → runPythonAnalysis (pandas aggregation, matplotlib bar plot) → statistical verification of differences.

"Draft LaTeX review on guava antimicrobial mechanisms"

Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Rabe 1997 et al.) → latexCompile → PDF output with figure captions.

"Find code for analyzing guava nanoparticle antibacterial data"

Research Agent → paperExtractUrls (Santhoshkumar 2014) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on shared scripts for TiO2 MIC simulations.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers (50+ guava antimicrobial papers) → citationGraph clustering → GRADE-graded summary report on efficacy trends. DeepScan applies 7-step analysis with CoVe checkpoints to verify Arima and Danno (2002) compound isolation claims against modern assays. Theorizer generates hypotheses on synergism mechanisms from Betoni et al. (2006) and Chah et al. (2005) data.

Try Doxa for Antimicrobial Properties of Psidium guajava Research

Frequently Asked Questions

What defines antimicrobial properties of Psidium guajava?

Activities of leaf/fruit extracts inhibiting bacteria like S. aureus and E. coli via MIC determination and membrane disruption (Biswas et al., 2013).

What are key methods used?

Disc diffusion, broth microdilution for MIC, and green synthesis for nanoparticles (Santhoshkumar et al., 2014); isolation of flavonoids like morin-3-O-glycoside (Arima and Danno, 2002).

What are foundational papers?

Rabe and Van Staden (1997, 564 citations) on plant antibacterials; Santhoshkumar et al. (2014, 503 citations) on TiO2 NPs; Betoni et al. (2006, 357 citations) on synergism.

What open problems exist?

Standardized extracts for clinical trials, molecular mechanisms beyond in vitro MIC, and scalability of nanoparticle synthesis (Chassagne et al., 2021).